Amplitude, Inc., together with its subsidiaries, provides an AI analytics platform that helps analyze customer behavior within digital products in the United States and internationally.
Screened 2026-09-17 · the tape above runs as of 21:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
The Label · The Season, Not the Day
This name holds its markup label.
Amplitude, Inc. holds its Markup at $13.81. Elevated stress, defensive posture warranted, held for 15 days.
As held on the ledger · 2026-09-17
Phase
Markup
Quantitative state
Elevated stress, defensive posture warranted, held for 15 days
Price at the screen
$13.81
Valuation
N/A trailing · 79.91 forward price to earnings
Values screen
PASS· score 70.0
Beta
1.50
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
2.27%
Below 33%
Interest-bearing debt is just 2.3% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
14.39%
Below 33%
Cash held in interest-bearing accounts and securities is 14.4% of assets, under the one-third limit.
Pass
Receivables
24.85%
Below 49%
Money owed to the company is 24.9% of assets, under the 49% limit.
Pass
Revenue purity
0.00%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
Fair value range in USD, drawn from the 2026-09-17 screen. The gold marker is the market price at the same screen. The price runs 38.6% above the base estimate.
Third-party analyst targets: 11 covering, consensus Buy. The average target sits −6% from the screen price.
Reading the gap · Both our model and the Street see limited upside at this price.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-17 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Analytics tool priced well beyond its worth
Picture a dashboard that follows every click inside an app. Amplitude sells that view to product teams, yet the business still loses a quarter of every dollar it brings in. At 71 times forward earnings with revenue growing just 17 percent, the shares sit 34 percent above our fair value. The market is paying up for a platform whose economics have yet to turn.
We pass because the numbers refuse to cooperate. Negative 35 percent return on equity and an unknown moat leave little room for error if growth slows or competition intensifies. Eleven analysts may still lean buy, but their median target barely clears the current price while the company continues to burn cash.
High multiples on unprofitable growth often compress when reality sets in. Currency moves or a single large customer loss would hurt quickly. Analysis, not advice.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
AMPL trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-08-21Markup$13.30+38.5%Entry 6
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 38.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it none, with a mean price target of $11.
2026-07-21Markup$9.60+39.3%Entry 5
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 39.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it none, with a mean price target of $11.
2026-07-18Markup$6.89+0.0%Entry 4
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it none, with a mean price target of $11.
2026-07-17Markup$6.89+0.0%Entry 3
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 45%. Our forward projection puts the odds of a 10% gain over the next month near 25%. The street (10 analysts) rates it none, with a mean price target of $11.
2026-07-03Markup$6.89+0.0%Entry 2
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02Markup$6.89Entry 1
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.